-
公开(公告)号:US20220241315A1
公开(公告)日:2022-08-04
申请号:US17596137
申请日:2020-05-29
Applicant: CancerStem Tech Inc. , OSAKA UNIVERSITY
Inventor: Hirofumi Yamamoto , Xin Wu
IPC: A61K31/713 , A61P35/00
Abstract: An object of the present invention is to provide a nucleic acid medicine for cancer treatment that makes it possible to treat cancer effectively. miR-4711-5p can suppress the expression of KLF5, TFDP1, and MDM2, as a result suppressing the proliferation, infiltration, and migration of cancer cells effectively, inducing apoptosis and G1 arrest, and also lowering stemness.
-
公开(公告)号:US20210052627A1
公开(公告)日:2021-02-25
申请号:US16498986
申请日:2018-03-30
Applicant: CancerStem Tech Inc.
Inventor: Xin Wu , Masaki Mori , Hirofumi Yamamoto
IPC: A61K31/7105 , A61P35/00 , C12N15/113
Abstract: The purpose of the present invention is to provide a nucleic acid medication for cancer treatment, the medication being capable of suppressing the growth of cancer stem cells and thus effectively treating cancer. hsa-miR-136-5p, hsa-miR-3065-3p, hsa-miR-4727-5p, hsa-miR-378g, hsa-miR-181a-5p, hsa-miR-362-5p, and hsa-miR-608 have remarkably excellent growth inhibitory action on cancer stem cells and are thus useful as a nucleic acid medication for the treatment of various cancers.
-
公开(公告)号:US11439657B2
公开(公告)日:2022-09-13
申请号:US16498986
申请日:2018-03-30
Applicant: CancerStem Tech Inc.
Inventor: Xin Wu , Masaki Mori , Hirofumi Yamamoto
IPC: C07H21/02 , C07H21/04 , A61K31/7105 , A61P35/00 , C12N15/113 , A61K45/06
Abstract: The purpose of the present invention is to provide a nucleic acid medication for cancer treatment, the medication being capable of suppressing the growth of cancer stem cells and thus effectively treating cancer. hsa-miR-136-5p, hsa-miR-3065-3p, hsa-miR-4727-5p, hsa-miR-378g, hsa-miR-181a-5p, hsa-miR-362-5p, and hsa-miR-608 have remarkably excellent growth inhibitory action on cancer stem cells and are thus useful as a nucleic acid medication for the treatment of various cancers.
-
公开(公告)号:US20200040307A1
公开(公告)日:2020-02-06
申请号:US16499094
申请日:2018-03-30
Applicant: CancerStem Tech Inc.
Inventor: Xin Wu , Masaki Mori , Hirofumi Yamamoto
Abstract: The purpose of the present invention is to provide: a cancer stem cell having an excellent ability to form tumor tissue; and a method for establishing the cancer stem cell. Cells having a low metabolic function of 26S proteasome are isolated and concentrated from a cancer stem cell group containing cancer stem cells, thereby obtaining cancer stem cells which can form tumor tissue in a living body even when the number of cells is 200 or less.
-
公开(公告)号:US11321841B2
公开(公告)日:2022-05-03
申请号:US16766333
申请日:2018-11-05
Applicant: OSAKA UNIVERSITY
Inventor: Kazuaki Nakane , Hirofumi Yamamoto , Mizuho Nishio
Abstract: In order to assess, with high accuracy, a degree of a change having occurred in a structure, the present invention includes: a Betti number calculating section (42) configured to (I) generate, with respect to a single captured image obtained by capturing an image of a structure, a plurality of binarized images having respective binarization reference values different from each other and (II) calculate, for each of the plurality of binarized images, a first characteristic numerical value indicative of the number of connected regions each of which is obtained by connecting pixels each having one of pixel values obtained by binarization; and a prediction score determining section (44) configured to determine, in accordance with a result of a comparison, information on a change having occurred in the structure, the comparison having been made between (i) a pattern indicative of a relationship between (a) the respective binarization reference values and (b) the first characteristic numerical value and (ii) a predetermined reference pattern.
-
公开(公告)号:US11226330B2
公开(公告)日:2022-01-18
申请号:US16249527
申请日:2019-01-16
Applicant: SUMITOMO RUBBER INDUSTRIES, LTD. , YAMAGATA UNIVERSITY , OSAKA UNIVERSITY
Inventor: Yasuhisa Minagawa , Masaru Tanaka , Takashi Hoshiba , Haruka Emura , Masaki Mori , Hirofumi Yamamoto , Naotsugu Haraguchi
IPC: G01N33/50 , B01D21/26 , G01N33/574 , G01N33/543
Abstract: The present invention provides a method for capturing specific cells (e.g. many types of cancer cells, including cancer cells not expressing EpCAM) and a method for analysis of specific cells involving the method. Included is a method for capturing specific cells present in blood or biological fluid, the method including: subjecting sampled blood or biological fluid to enrichment; and capturing specific cells therefrom onto a hydrophilic polymer layer in a flow field.
-
公开(公告)号:US12039722B2
公开(公告)日:2024-07-16
申请号:US17442499
申请日:2020-02-12
Applicant: OSAKA UNIVERSITY
Inventor: Kazuaki Nakane , Hirofumi Yamamoto , Sachiko Nankumo , Yasuyoshi Tsutsumi
CPC classification number: G06T7/0012 , G16H30/40 , G16H50/80 , G06T2207/30024 , G06T2207/30096
Abstract: By analyzing an image of a cell sample, whether a cell shown in the image is cancerous or not, the type of cancer, etc. are objectively and appropriately determined. An image analyzing device (1) includes: a binarizing section (41) which carries out a binarizing process a plurality of times with respect to a single captured image so as to generate a plurality of binarized images, the binarizing section carrying out the binarizing process each time the binarizing section varies a binarization reference value; a Betti number calculating section (42) which calculates a region number, which indicates the number of hole-shaped regions, with respect to each of the plurality of binarized images which have been generated; and a cancer determining section (43) which determines a type of cancer occurring in a cell included in tissue, on the basis of the binarization reference value which has been applied at a time of generation of one of the plurality of binarized images with respect to which one the region number has a given value.
-
公开(公告)号:US11077167B2
公开(公告)日:2021-08-03
申请号:US16619879
申请日:2018-06-12
Applicant: Osaka University
Inventor: Susumu Tanaka , Mikihiko Kogo , Hirofumi Yamamoto , Naomasa Kawaguchi , Yoshinosuke Hamada
Abstract: The present invention provides an agent for promoting skeletal muscle injury repair which agent comprises at least one peptide selected from the following (1) to (4): (1) a peptide consisting of the amino acid sequence of SEQ ID NO: 1, (2) a peptide consisting of the amino acid sequence of SEQ ID NO: 2, (3) a peptide consisting of the amino acid sequence of SEQ ID NO: 3, and (4) a peptide which is a human osteopontin fragment and has the amino acid sequence of SEQ ID NO: 1, 2, or 3 at the C-terminus, or a salt thereof as an active ingredient.
-
-
-
-
-
-
-